Hook and thesis
If the recent 'SaaSpocalypse' headlines - and the knock-on selling in private credit and asset managers - have you skittish about financial names, Ares Management (ARES) offers a way to own the private credit story without making an all-or-nothing tech-lender bet. Ares is a diversified alternative asset manager with a large, stable Credit Group and an expanding set of strategies that can generate fee and distributable income even if pockets of the market reprice.
Our trade idea is simple: buy ARES on modest weakness, position for mean reversion from depressed sentiment, and ride a recovery in valuation multiple as liquidity concerns fade and realized fees from added assets flow through. Entry, stop and target below reflect current technicals and the firm's fundamentals.
What Ares does and why it matters
Ares Management is an alternative asset manager operating across five groups - Credit, Private Equity, Real Assets, Secondaries and Other. The Credit Group covers liquid and illiquid strategies, direct lending and Asia-Pacific credit. Ares’ scope makes it less dependent on any single sector or concentrated tech credit books that spooked markets recently.
Why the market should care: asset managers trade on AUM, fee-rate stability and distributable income. Ares continues to add assets through M&A and organic growth - it completed the acquisition of London-based BlueCove on 02/03/2026, folding about $5.5 billion of AUM into its systematic credit franchise and lifting the firm’s stated assets under management to roughly $397 billion as of 09/30/2025. That scale matters: durable AUM plus diversified product mix smooths out headline risk when specialized private credit vehicles face redemption pressure.
Numbers that support the case
- Market cap and enterprise value: Ares' market cap sits around $35.4 billion with enterprise value near $34.3 billion, putting the firm in the large-cap alternative manager cohort and giving it balance-sheet scale to support credit platforms.
- Profitability and returns: reported return on equity is healthy at roughly 13.5%, showing attractive cash generation vs. capital. Return on assets is more modest at about 2.24% - typical for fee-generating asset managers with large AUM and relatively low fixed-asset bases.
- Balance sheet: debt-to-equity is elevated at about 2.69 - this is not unusual for a manager with capital-markets businesses and balance-sheet-led credit strategies, but it does increase sensitivity to credit-market stress.
- Valuation context: Ares' trailing P/E appears elevated if you use a certain snapshot (P/E in the 39-60x area depending on the calculation), but alternative manager valuations are driven by fee-bearing AUM and distributable economics rather than headline P/E alone. Enterprise multiples show EV/EBITDA around 32x, which feels rich on surface but must be read against recurring fee margins and a sizable free-cash-flow base.
- Market technicals and sentiment: ARES has pulled back from a 52-week high of $195.26 (08/13/2025) to trade near $107.51 today, and hit a 52-week low of $95.80 on 03/12/2026 - this places current price nearer the downside than the peak. Short interest has ticked up recently - settlement on 02/27/2026 recorded ~12.13 million shares short, with days-to-cover roughly 2.6 - a sign that the name is a visible target in the current financial selloff.
Valuation framing
At a market cap roughly in the mid-$30 billions and enterprise value in the mid-$30 billions, Ares is priced for a reasonably high-quality alternative manager but with a meaningful haircut from its peak. The current price sits near the lower end of the 52-week range, implying the market is discounting either a prolonged AUM outflow, materially lower fee margins or credit losses on balance-sheet exposures.
Those scenarios are real risks, but Ares' diversified product base - credit, PE, real assets and secondaries - gives it multiple fee engines. Compare that to single-strategy players that have taken bigger hits when private-credit redemption events occur. In short, the valuation looks opportunistic if you believe yield-hungry investors rotate back into scale managers and if Ares can keep fee growth positive.
Catalysts to push the trade higher
- Fee and AUM stabilization - any quarterly report showing AUM growth or slower outflows will materially re-rate sentiment.
- Positive earnings/earnings-per-share prints driven by realized gains or higher management fees as systematic credit business scales.
- Further accretive M&A or bolt-on deals that add fee-bearing assets (BlueCove is an example completed on 02/03/2026) and improve recurring revenue.
- Broader market stabilization in financials and private-credit liquidity - a calming in redemption activity across the sector would relieve the price pressure typical in panic-deleveraging episodes.
Actionable trade plan
| Trade | Entry | Stop | Target | Time horizon |
|---|---|---|---|---|
| Buy ARES | $106.50 | $96.00 | $140.00 | Mid term (45 trading days) |
Why these levels? Entering at $106.50 gives a modest buffer under today's $107.51 and respects recent intraday swings (today's low was $106.24). A stop at $96.00 sits just above the 52-week low of $95.80; a break below that low would signal further downside and justify limiting loss. The $140 target assumes a re-rating toward the mid-point between the current price and the prior consolidation range - an achievable move if catalysts above begin to click and sector panic recedes.
Time and trade management
We view this as a mid-term swing (45 trading days). That's long enough to let a quarterly earnings or AUM/data-flow update land, but not a buy-and-pray multi-quarter position. If the trade hits the target before 45 trading days because of a positive catalyst (e.g., an earnings beat and visible AUM inflows), traders should take profits. If the trade is underwater but the thesis remains intact, consider trimming position size rather than doubling down.
Risks and counterarguments
Below are the main risks that could invalidate this trade:
- Private-credit liquidity shock - further redemption freezes or forced liquidations at depressed prices could hit fee generation and capital-markets confidence across managers. Ares has balance-sheet exposures; sustained stress could compress its distributable income and valuations.
- Macro shock to credit markets - rising defaults or a rapid tightening in credit spreads would stress Ares’ credit strategies and potentially reduce AUM as investors flee riskier private-credit buckets.
- Execution and integration risk - acquisitions like BlueCove add AUM but carry integration risk. If accretion is slower than expected, expected fee growth will lag and the multiple may compress further.
- Leverage sensitivity - Ares’ debt-to-equity near ~2.69 leaves it more exposed to rising funding costs and mark-to-market swings than a purely fee-only manager; that amplifies downside in stress.
- Valuation headwinds - even without operational deterioration, multiple contraction in the asset-management sector could keep the stock capped for an extended period.
Counterargument: skeptics will rightly say that the recent price action is telling you something - specialized private-credit managers and even some broadly diversified managers have been hit as redemption risk and concentration into tech-credit have filtered across the sector. One could argue that until redemption flows and client confidence fully normalize, owning a large manager like Ares still carries material downside because headline risk can cascade and take multiples lower across the board.
Why we still like this entry
We accept the skeptic’s point, but highlight that Ares’ business is broad: Credit is large and diversified across liquid and illiquid strategies, PE and Real Assets add non-correlated fee streams, and secondaries help monetize existing holdings when markets are dislocated. The BlueCove deal (closed on 02/03/2026) increases the systematic fixed-income footprint and should boost recurring revenue if it scales as advertised. Trading nearer the 52-week low also provides a defined risk-reward if you follow the stop described above.
What would change our mind
We would reconsider the long bias if any of the following occur:
- Ares reports meaningful AUM outflows on the next public AUM update or quarterly report, especially concentrated in fee-bearing strategies.
- There is evidence of sustained mark-to-market losses or credit defaults in Ares’ balance-sheet-led funds that force asset sales or capital raises.
- Sector-wide contagion intensifies - e.g., multiple large alternative managers report redemption freezes or material redemptions that suggest the problem is systemic rather than idiosyncratic.
Bottom line
For investors looking to convert fear of a tech-led private-credit shock into an opportunity, Ares is a pragmatic way to play a recovery in alternative-manager sentiment. The firm's scale, diversified fee base and completed bolt-ons like BlueCove provide tangible levers for fee growth even if certain pockets of credit remain under pressure. The proposed trade - buy at $106.50, stop $96.00, target $140.00 - offers a defined risk-reward over a mid-term 45 trading-day horizon while recognizing the real risks around liquidity and leverage.
If catalysts start to line up - AUM stabilization, earnings beats and calmer redemption headlines - ARES should re-rate. If the opposite happens, the stop protects capital while leaving the door open to reassess on any sustained stabilization in credit markets.
Ex-dividend date: 03/17/2026. Payable date: 03/31/2026.